サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1439532

尿路閉塞治療機器 - 世界市場の考察、競合情勢、市場予測（2030年）

Urinary Tract Obstruction Treatment Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日: 受注後更新 | 発行: DelveInsight | ページ情報: 英文 150 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
尿路閉塞治療機器 - 世界市場の考察、競合情勢、市場予測（2030年）
出版日: 受注後更新
発行: DelveInsight
ページ情報: 英文 150 Pages
納期: 2～10営業日
ご注意事項 :
本レポートの納品は、最新情報反映のため受注時に適宜更新しお届けいたします。
更新情報の反映作業にあたり納期もレポート毎に異なりますので、ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の尿路閉塞治療機器の市場規模は、2024年～2030年の予測期間にCAGRで4.2％の成長が見込まれます。市場は膀胱がん、前立腺肥大症、尿路結石、腎結石などの泌尿器科疾患の症例の増加により、プラス成長を示しています。また、危険因子である肥満などの座りがちなライフスタイル、製品設計の革新、世界の老年人口の増加、外科手術数の増加が、2024年～2030年の予測期間の市場成長に寄与します。

尿路閉塞治療機器の市場力学

尿路閉塞治療機器市場は、さまざまな要因によって製品需要が増加しています。主な要因は、世界中での膀胱がん、前立腺肥大症、尿路結石、腎結石などの泌尿器疾患の症例の増加などです。

尿路閉塞のもっとも一般的な原因は、結石、血栓、腫瘍、剥がれた乳頭です。これらの閉塞は急速に現れ、脇腹痛、血尿、吐き気、嘔吐、発熱を伴う重度の腎疝痛を引き起こします。

The Urology Foundation（2022）によると、前立腺肥大症（BPH）の罹患率は、50～60歳の男性の50％から、80歳以上の男性では90％に増加すると推定されています。突然尿が出なくなる（急性尿路閉塞と呼ばれる）男性もいます。

European Association of Urology（2019）によると、尿路結石の有病率は1％から20％と幅があり、カナダ、スウェーデン、米国など生活水準の高い国では、腎結石の有病率はかなり高い（10％以上）です。

National Kidney Foundation（2022）によると、毎年50万人以上が腎臓結石の問題で救急外来を受診しています。

さらに、アルコールの過剰摂取や水分摂取の減少など、座りがちなライフスタイルの増加も腎結石の発症につながります。さらに、食生活の乱れや運動不足などの座りがちな生活習慣により、腎結石発症の危険因子である肥満の負担が増加していることも、尿路閉塞治療機器市場の成長に寄与します。

世界保健機関（WHO）（2022）のデータによると、2016年の世界の肥満人口は約6億5,000万人でした。また、さまざまな研究によると、肥満の人々は尿酸結石やシュウ酸カルシウム結石をより多く発症し、体内からの尿の正常な通過をさらに妨げています。

また、老年人口は末期腎不全になりやすいです。World Population Prospects（2019）によると、2019年の65歳以上の高齢者は世界で7億300万人です。したがって、老年人口が増加するにつれて尿路結石の有病率が増加し、結果として尿路閉塞治療機器の需要を押し上げ、世界の尿路閉塞治療機器市場の成長を促進します。

しかし、機器の高いコストや有害事象などの特定の要因が、尿路閉塞治療機器市場成長の一定の抑制要因となる可能性があります。

COVID-19パンデミックの発生により、救急外来の受診が大幅に減少しました。さらに、外来診療の予約に遅れが生じ、バーチャル診療や電話診療の必要性が高まっています。病院内のベッド、麻酔や処置の枠、医療従事者の不足により、これらの変化は多くの未処理の治療を生み、世界の尿路閉塞治療機器市場にマイナスの影響を与えました。

尿路閉塞治療機器市場のセグメント分析

尿路閉塞治療機器市場の治療セグメントでは、体外衝撃波結石破砕機が予測期間（2024年～2030年）に尿路閉塞治療機器市場で高いシェアを占める見込みです。これは、これらの機器に関連する特定の機能によるものと考えられます。

この製品セグメントの高い市場シェアは、これらの機器を採用する患者の増加と迅速な治療によるものと考えられます。ESWLの主な利点は、結石の治療に皮膚の切開や侵襲的な手術機器の使用を伴わないため、治療が完全に非侵襲であることです。代わりに衝撃波を利用して結石を細かく砕き、尿管を通って膀胱から排出します。

当レポートでは、世界の尿路閉塞治療機器市場について調査分析し、市場規模と予測、促進要因と課題、企業と製品のプロファイルなどを提供しています。

目次

第1章 尿路閉塞治療機器市場レポートのイントロダクション

第2章 尿路閉塞治療機器市場のエグゼクティブサマリー

  • 調査範囲
  • 市場の概要
  • 競合の評価
  • 財務ベンチマーク

第3章 規制と特許の分析

  • 米国
  • 欧州
  • 日本
  • 中国

第4章 尿路閉塞治療機器市場の主な要因の分析

  • 尿路閉塞治療機器市場の促進要因
    • 泌尿器疾患の症例の増加
    • 危険因子としての座りがちなライフスタイル
    • 製品設計の革新
    • 世界中での老年人口の増加
  • 尿路閉塞治療機器市場の抑制要因と課題
    • 機器の高いコスト
    • 有害事象
  • 尿路閉塞治療機器市場の機会
    • 不正確な診断と治療の困難を排除する先進の機器の必要性
    • 新興国における低侵襲機器への選好の高まり

第5章 尿路閉塞治療機器市場のポーターのファイブフォース分析

第6章 尿路閉塞治療機器市場に対するCOVID-19の影響分析

第7章 尿路閉塞治療機器の市場レイアウト

  • 製品別
    • 尿道カテーテル
    • 尿路ステント
    • 衝撃波結石破砕機
    • 尿管鏡
    • レゼクトスコープ
    • 結石回収機器
    • レーザー治療システム
    • その他
  • 適応症別
    • がん
    • 結石
    • 前立腺肥大症（BPH）
    • 水腎症
  • エンドユーザー別
    • 病院
    • 外来手術センター
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋
    • その他の地域

第8章 尿路閉塞治療機器市場：世界の企業シェア分析 - 主要3～5社

第9章 尿路閉塞治療機器市場の企業と製品のプロファイル

  • Boston Scientific Corporation
  • B. Braun Melsungen AG
  • Advin Health Care
  • Inceler Medikal Co. Ltd.
  • Walz Elektronik GmbH
  • Cook
  • Becton, Dickinson, and Company
  • Teleflex Incorporated
  • STORZ MEDICAL AG
  • Olympus
  • EMS Urology
  • Dornier Medtech
  • Shockwave Medical Inc.
  • ACE Medical Devices Pvt. Ltd.
  • Applied Medical Resources Corporation
  • Richard Wolf GmbH
  • Stryker
  • Urocare Products, Inc.
  • J and M Urinary Catheters LLC
  • Rocamed

第10章 KOLの見解

第11章 プロジェクトのアプローチ

第12章 DelveInsightについて

第13章 免責事項とお問い合わせ

図表

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: COVID-19 Impact Analysis
  • Table 3: Urinary Tract Obstruction Treatment Devices Market in Global (2021-2030)
  • Table 4: Urinary Tract Obstruction Treatment Devices Market in Global by Product (2021-2030)
  • Table 5: Urinary Tract Obstruction Treatment Devices Market in Global by Indication (2021-2030)
  • Table 6: Urinary Tract Obstruction Treatment Devices Market in Global by End User (2021-2030)
  • Table 7: Urinary Tract Obstruction Treatment Devices Market in Global by Geography (2021-2030)
  • Table 8: Urinary Tract Obstruction Treatment Devices Market in North America (2021-2030)
  • Table 9: Urinary Tract Obstruction Treatment Devices Market in North America by Product (2021-2030)
  • Table 10: Urinary Tract Obstruction Treatment Devices Market in North America by Indication (2021-2030)
  • Table 11: Urinary Tract Obstruction Treatment Devices Market in North America by End User (2021-2030)
  • Table 12: Urinary Tract Obstruction Treatment Devices Market in North America by Country (2021-2030)
  • Table 13: Urinary Tract Obstruction Treatment Devices Market in the US (2021-2030)
  • Table 14: Urinary Tract Obstruction Treatment Devices Market in Canada (2021-2030)
  • Table 15: Urinary Tract Obstruction Treatment Devices Market in Mexico (2021-2030)
  • Table 16: Urinary Tract Obstruction Treatment Devices Market in Europe (2021-2030)
  • Table 17: Urinary Tract Obstruction Treatment Devices Market in Europe by Product (2021-2030)
  • Table 18: Urinary Tract Obstruction Treatment Devices Market in Europe by Indication (2021-2030)
  • Table 19: Urinary Tract Obstruction Treatment Devices Market in Europe by End User (2021-2030)
  • Table 20: Urinary Tract Obstruction Treatment Devices Market in Europe by Country (2021-2030)
  • Table 21: Urinary Tract Obstruction Treatment Devices Market in France (2021-2030)
  • Table 22: Urinary Tract Obstruction Treatment Devices Market in Germany (2021-2030)
  • Table 23: Urinary Tract Obstruction Treatment Devices Market in the United Kingdom (2021-2030)
  • Table 24: Urinary Tract Obstruction Treatment Devices Market in Italy (2021-2030)
  • Table 25: Urinary Tract Obstruction Treatment Devices Market in Spain (2021-2030)
  • Table 26: Urinary Tract Obstruction Treatment Devices Market in Russia (2021-2030)
  • Table 27: Urinary Tract Obstruction Treatment Devices Market in Rest of Europe (2021-2030)
  • Table 28: Urinary Tract Obstruction Treatment Devices Market in APAC (2021-2030)
  • Table 29: Urinary Tract Obstruction Treatment Devices Market in APAC by Product (2021-2030)
  • Table 30: Urinary Tract Obstruction Treatment Devices Market in APAC by Indication (2021-2030)
  • Table 31: Urinary Tract Obstruction Treatment Devices Market in APAC by End User (2021-2030)
  • Table 32: Urinary Tract Obstruction Treatment Devices Market in APAC by Country (2021-2030)
  • Table 33: Urinary Tract Obstruction Treatment Devices Market in China (2021-2030)
  • Table 34: Urinary Tract Obstruction Treatment Devices Market in Japan (2021-2030)
  • Table 35: Urinary Tract Obstruction Treatment Devices Market in India (2021-2030)
  • Table 36: Urinary Tract Obstruction Treatment Devices Market in Australia (2021-2030)
  • Table 37: Urinary Tract Obstruction Treatment Devices Market in South Korea (2021-2030)
  • Table 38: Urinary Tract Obstruction Treatment Devices Market in Rest of APAC (2021-2030)
  • Table 39: Urinary Tract Obstruction Treatment Devices Market in Rest of World (2021-2030)
  • Table 40: Urinary Tract Obstruction Treatment Devices Market in RoW by Product (2021-2030)
  • Table 41: Urinary Tract Obstruction Treatment Devices Market in RoW by Indication (2021-2030)
  • Table 42: Urinary Tract Obstruction Treatment Devices Market in RoW by End User (2021-2030)
  • Table 43: Urinary Tract Obstruction Treatment Devices Market in RoW by Region (2021-2030)
  • Table 44: Urinary Tract Obstruction Treatment Devices Market in Middle East (2021-2030)
  • Table 45: Urinary Tract Obstruction Treatment Devices Market in Africa (2021-2030)
  • Table 46: Urinary Tract Obstruction Treatment Devices Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: COVID-19 Impact Analysis
  • Figure 3: Urinary Tract Obstruction Treatment Devices Market in Global (2021-2030)
  • Figure 4: Urinary Tract Obstruction Treatment Devices Market in Global by Product (2021-2030)
  • Figure 5: Urinary Tract Obstruction Treatment Devices Market in Global by Indication (2021-2030)
  • Figure 6: Urinary Tract Obstruction Treatment Devices Market in Global by End User (2021-2030)
  • Figure 7: Urinary Tract Obstruction Treatment Devices Market in Global by Geography (2021-2030)
  • Figure 8: Urinary Tract Obstruction Treatment Devices Market in North America (2021-2030)
  • Figure 9: Urinary Tract Obstruction Treatment Devices Market in North America by Product (2021-2030)
  • Figure 10: Urinary Tract Obstruction Treatment Devices Market in North America by Indication (2021-2030)
  • Figure 11: Urinary Tract Obstruction Treatment Devices Market in North America by End User (2021-2030)
  • Figure 12: Urinary Tract Obstruction Treatment Devices Market in North America by Country (2021-2030)
  • Figure 13: Urinary Tract Obstruction Treatment Devices Market in the US (2021-2030)
  • Figure 14: Urinary Tract Obstruction Treatment Devices Market in Canada (2021-2030)
  • Figure 15: Urinary Tract Obstruction Treatment Devices Market in Mexico (2021-2030)
  • Figure 16: Urinary Tract Obstruction Treatment Devices Market in Europe (2021-2030)
  • Figure 17: Urinary Tract Obstruction Treatment Devices Market in Europe by Product (2021-2030)
  • Figure 18: Urinary Tract Obstruction Treatment Devices Market in Europe by Indication (2021-2030)
  • Figure 19: Urinary Tract Obstruction Treatment Devices Market in Europe by End User (2021-2030)
  • Figure 20: Urinary Tract Obstruction Treatment Devices Market in Europe by Country (2021-2030)
  • Figure 21: Urinary Tract Obstruction Treatment Devices Market in France (2021-2030)
  • Figure 22: Urinary Tract Obstruction Treatment Devices Market in Germany (2021-2030)
  • Figure 23: Urinary Tract Obstruction Treatment Devices Market in the United Kingdom (2021-2030)
  • Figure 24: Urinary Tract Obstruction Treatment Devices Market in Italy (2021-2030)
  • Figure 25: Urinary Tract Obstruction Treatment Devices Market in Spain (2021-2030)
  • Figure 26: Urinary Tract Obstruction Treatment Devices Market in Russia (2021-2030)
  • Figure 27: Urinary Tract Obstruction Treatment Devices Market in Rest of Europe (2021-2030)
  • Figure 28: Urinary Tract Obstruction Treatment Devices Market in APAC (2021-2030)
  • Figure 29: Urinary Tract Obstruction Treatment Devices Market in APAC by Product (2021-2030)
  • Figure 30: Urinary Tract Obstruction Treatment Devices Market in APAC by Indication (2021-2030)
  • Figure 31: Urinary Tract Obstruction Treatment Devices Market in APAC by End User (2021-2030)
  • Figure 32: Urinary Tract Obstruction Treatment Devices Market in APAC by Country (2021-2030)
  • Figure 33: Urinary Tract Obstruction Treatment Devices Market in China (2021-2030)
  • Figure 34: Urinary Tract Obstruction Treatment Devices Market in Japan (2021-2030)
  • Figure 35: Urinary Tract Obstruction Treatment Devices Market in India (2021-2030)
  • Figure 36: Urinary Tract Obstruction Treatment Devices Market in Australia (2021-2030)
  • Figure 37: Urinary Tract Obstruction Treatment Devices Market in South Korea (2021-2030)
  • Figure 38: Urinary Tract Obstruction Treatment Devices Market in Rest of APAC (2021-2030)
  • Figure 39: Urinary Tract Obstruction Treatment Devices Market in Rest of World (2021-2030)
  • Figure 40: Urinary Tract Obstruction Treatment Devices Market in RoW by Product (2021-2030)
  • Figure 41: Urinary Tract Obstruction Treatment Devices Market in RoW by Indication (2021-2030)
  • Figure 42: Urinary Tract Obstruction Treatment Devices Market in RoW by End User (2021-2030)
  • Figure 43: Urinary Tract Obstruction Treatment Devices Market in RoW by Region (2021-2030)
  • Figure 44: Urinary Tract Obstruction Treatment Devices Market in Middle East (2021-2030)
  • Figure 45: Urinary Tract Obstruction Treatment Devices Market in Africa (2021-2030)
  • Figure 46: Urinary Tract Obstruction Treatment Devices Market in South America (2021-2030)
  • Figure 47: Market Drivers
  • Figure 48: Market Barriers
  • Figure 49: Marker Opportunities
  • Figure 50: PORTER'S Five Force Analysis
目次
Product Code: DIMDCL0354

Urinary Tract Obstruction Treatment Devices Market By Product (Urinary Catheters [Indwelling/Foley Catheters, Intermittent Catheters, External Catheters], Urinary Stents, Shock Wave Lithotripters [Intracorporeal, Extracorporeal], Ureteroscopes [Semi-Rigid, Flexible], Resectoscopes, Stone Retrieval Devices, Laser Therapy Systems, Others), By Indication (Cancers, Stones, Benign Prostatic Hyperplasia (BPH), Hydronephrosis, Others), By End-User (Hospitals, Ambulatory Surgical Centers, Others), by geography is expected to grow at a steady CAGR forecast till 2030 owing to growing cases of urological disorders and innovation in product design

Global Urinary Tract Obstruction Treatment Devices Market growing at a CAGR of 4.2% during the forecast period from 2024 to 2030. The Urinary Tract Obstruction Treatment Devices market is witnessing positive growth owing to the growing cases of urological disorders such as bladder cancers, Benign Prostatic Hyperplasia, urolithiasis, or nephrolithiasis, among others. In addition, sedentary lifestyle such as obesity which is a risk factor, innovation in product design, rising old age population across the globe, increase in the number of surgical procedures is thereby contributing to the growth of the Urinary Tract Obstruction Treatment Devices market during the forecast period from 2024-2030.

Urinary Tract Obstruction Treatment Devices Market Dynamics:

The Urinary Tract Obstruction Treatment Devices market is witnessing a growth in product demand owing to various reasons. The key factor includes the growing cases of urological disorders such as bladder cancers, Benign Prostatic Hyperplasia, urolithiasis, or nephrolithiasis, among others across the globe.

The most common causes of urinary obstruction are calculi, blood clots, tumors, or sloughed papilla. These obstructions present acutely, leading to severe renal colic with flank pain, hematuria, nausea, vomiting, and fever.

As per The Urology Foundation 2022, the incidence of benign prostatic hyperplasia (BPH), was estimated to increase from 50% among men between the ages of 50 and 60 years to 90% for men older than 80 years of age. Some men experience a sudden onset of the inability to pass urine (known as acute retention).

According to the European Association of Urology 2019, the prevalence rates for urinary stones vary from 1% to 20%, and in the countries with a high standard of life such as Canada, Sweden, or the US, renal stones prevalence is significantly high (>10%).

According to the National Kidney Foundation 2022, over half a million people go to emergency rooms for kidney stone problems every year.

Moreover, a rise in sedentary lifestyle such as excessive consumption of alcohol, and less consumption of water can also lead to the development of kidney stones. In addition, the growing burden of obesity among the population, a higher risk factor for the development of renal calculi, due to sedentary lifestyles such as poor dietary habits and lack of physical activities will also contribute to the Urinary Tract Obstruction Treatment Devices market growth.

As per the World Health Organization (WHO) 2022 data, there was around 650 million obese population worldwide in the year 2016. Also, according to various studies, obese people develop more uric acid stones and calcium oxalate stones, which further hinder the normal passing of urine from the body.

Also, the aging population is more prone to the risk of end-stage renal failure. As per the World Population Prospects, 2019, there were 703 million older persons aged 65 or over in 2019 globally. Therefore, as the aging population increases, there will be more prevalence of urolithiasis, which will eventually boost the demand for Urinary Tract Obstruction Treatment Devices which will drive the growth of the Global Urinary Tract Obstruction Treatment Devices market.

However, certain factors such as the high cost of devices and the adverse events may be certain limiting factors to the Urinary Tract Obstruction Treatment Devices market growth.

The outbreak of the COVID-19 pandemic caused a significant decrease in emergency department visits. Moreover, there was a delay in outpatient clinic appointments which pushed the need for virtual or telephone clinics. Due to a lack of in-hospital beds, anesthesia or procedural slots, and healthcare professionals, these changes created a significant backlog in the treatment, thereby creating a negative impact on the Global Urinary Tract Obstruction Treatment Devices market.

Urinary Tract Obstruction Treatment Devices Market Segment Analysis:

Urinary Tract Obstruction Treatment Devices Market By Product (Urinary Catheters [Indwelling/Foley Catheters, Intermittent Catheters, External Catheters], Urinary Stents, Shock Wave Lithotripters [Intracorporeal, Extracorporeal], Ureteroscopes [Semi-Rigid, Flexible], Resectoscopes, Stone Retrieval Devices, Laser Therapy Systems, Others), By Indication (Cancers, Stones, Benign Prostatic Hyperplasia (BPH), Hydronephrosis, Others), By End-User (Hospitals, Ambulatory Surgical Centers, Others), and By Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the Treatment segment of the Urinary Tract Obstruction Treatment Devices market, the Extracorporeal Shock Wave Lithotripters are estimated to hold a higher share in the Urinary Tract Obstruction Treatment Devices market during the forecast period (2024-2030). This can be attributed to the specific features associated with these devices.

The large market share of this product segment can be attributed to the growing patient adoption of these devices and quick treatment. The main benefit of ESWL is that the treatment is totally non-invasive, as it does not involve any skin incisions or the use of any invasive surgical instruments to treat the stone. Instead, shock waves are utilized to shatter the stone into tiny fragments that flow through the ureter and out of the bladder.

It also has other advantages such as reduced pain, quick recovery time, and shorter hospital stays. This treatment method is chosen by a majority of the patient and physician population.

ESWL is suited for small stones as well as certain stones are present in the upper portion of the ureter. Moreover, multiple stones can also be treated with ESWL. Therefore, it is expected that with such advantages offered by the Extracorporeal Shock Wave Lithotripsy Devices this technology is expected to increase its penetration in the coming years, thus this will drive the segment to grow during the forecast period, which will have a positive impact on the overall Global Urinary Tract Obstruction Treatment Devices Market growth.

Furthermore, Extracorporeal Shock Wave Lithotripsy Devices are gaining commercial acceptability, which also improves market penetration. All these advantages of these devices make physicians more inclined to use Extracorporeal Shock Wave Lithotripsy Devices.

Hence, all the above-mentioned factors are expected to drive the segment growth of the Urinary Tract Obstruction Treatment Devices market.

North America is expected to dominate the overall Urinary Tract Obstruction Treatment Devices Market:

Among all the regions, North America is expected to account for the largest share in the Global Urinary Tract Obstruction Treatment Devices market during the year 2022. Factors such as the growing cases of urological disorders such as bladder and prostate cancers, urolithiasis, or nephrolithiasis, among others, and increased risk of end-stage renal failure among the population, rising product approvals are expected to aid in the growth of the North America Urinary Tract Obstruction Treatment Devices Market.

In the United States, high prostate cancer cases in the region increase the demand for urinary catheters as it causes difficulties in urination. For instance, as per the American Cancer Society 2022 statistics, about 248,530 new cases of prostate cancer are reported in the same year.

The rising cases of upper tract urothelial carcinoma (UTUC), is also the reason for an increase in the usage of Urinary Tract Obstruction Treatment Devices. For instance, as per the Centers for Disease Control and Prevention (CDC) 2020 data, approximately 17,500 women and 56,000 men suffer from bladder cancer in the US.

Moreover, according to the Canadian cancer society 2020 data, around 12,200 Canadians were suffering from bladder cancer in the year 2020.

As per the Canadian Urological Association guidelines 2022, globally, the prevalence of urolithiasis is steadily increasing, and though some regional variability exists, contemporary estimates report up to 10%-12% of men and 7%-8% of women now suffer from nephrolithiasis.

Moreover, according to the US Department of Health and Human Services 2022, end-stage renal disease (ESRD) is a significant public health problem in the United States and a major source of suffering and poor quality of life for those afflicted.

Another factor responsible for the growth of the Urinary Tract Obstruction Treatment Devices market is the launch of new products in the region. For instance, in 2019, Dornier Medtech launched and announced the immediate availability of its new AXIS single-use digital flexible ureteroscope in the US.

Thus, these factors are projected to contribute to the Urinary Tract Obstruction Treatment Devices market during the forecasted period.

Therefore, the interplay of various factors such as the presence of a large patient population, encouraging reimbursement policies as well as new product launches in the region is expected to boost the North America Urinary Tract Obstruction Treatment Devices market during the forecast period.

Urinary Tract Obstruction Treatment Devices Market Key Players:

Some of the key market players operating in the Urinary Tract Obstruction Treatment Devices market include B. Braun Melsungen AG, Boston Scientific Corporation, Cook, Becton, Dickinson, and Company, Teleflex Incorporated, Olympus, Dornier Medtech, EMS Urology, Advin Health Care, Inceler Medikal Co. Ltd., STORZ MEDICAL AG, Shockwave Medical Inc., ACE Medical Devices Pvt. Ltd., Walz Elektronik GmbH, Applied Medical Resources Corporation, Richard Wolf GmbH, Stryker, Urocare Products, Inc., J and M Urinary Catheters LLC, Rocamed and others.

Recent Developmental Activities in the Urinary Tract Obstruction Treatment Devices Market:

In March 2022, Boston Scientific acquired Lumenis in a $1.07 billion deal. With this acquisition, Boston Scientific has strengthened its product portfolio for Lithotripsy devices. This will further add to the growth of the Global Urinary Tract Obstruction Treatment Devices market.

In March 2022, Dornier MedTech GmbH became the world's first integrated urology company to be certified by the European Union's Medical Device Regulation (MDR). Dornier achieved the certification for its Class IIb products: Dornier Delta® III, one of the most powerful lithotripters that utilize Dornier's Extracorporeal Shock Wave Lithotripsy (ESWL) technology; and the Dornier UIMS(TM), a state-of-the-art information management software providing enhanced imaging and efficiency to support clinicians in treating kidney stones.

In August 2020, Olympus Winter & Ibe GmbH received the US FDA approval for OES Elite Ureteroscopes and Accessories under regulatory class II for endoscopic observation and therapy in the ureters, urethra, and urinary bladder.

In 2019, Shockwave Medical Inc. received breakthrough device designation for its intravascular lithotripsy (IVL) therapy, used for lithotripsy and was long used to eliminate kidney stones.

Key Takeaways from the Urinary Tract Obstruction Treatment Devices Market Report Study

  • Market size analysis for current Urinary Tract Obstruction Treatment Devices market size (2023), and market forecast for 5 years (2024-2030)
  • The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Urinary Tract Obstruction Treatment Devices market.
  • Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years
  • Key companies dominating the global Urinary Tract Obstruction Treatment Devices market.
  • Various opportunities available for the other competitor in the Urinary Tract Obstruction Treatment Devices market space.
  • What are the top performing segments in 2023? How these segments will perform in 2030?
  • Which is the top-performing regions and countries in the current Urinary Tract Obstruction Treatment Devices market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for Urinary Tract Obstruction Treatment Devices market growth in the coming future?

Target Audience who can be benefited from this Urinary Tract Obstruction Treatment Devices Market Report Study

  • Urinary Tract Obstruction Treatment Devices products providers
  • Research organizations and consulting companies
  • Urinary Tract Obstruction Treatment Devices-related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and Traders dealing in Urinary Tract Obstruction Treatment Devices
  • Various End-users who want to know more about the Urinary Tract Obstruction Treatment Devices market and latest technological developments in the Urinary Tract Obstruction Treatment Devices market.

Frequently Asked Questions for the Urinary Tract Obstruction Treatment Devices Market:

1. What are Urinary Tract Obstruction Treatment Devices?

Urinary Tract Obstruction Treatment Devices are devices used to treat obstruction which occurs in the course of urine from the kidney to the urethra.

2. What is the market for Global Urinary Tract Obstruction Treatment Devices?

Global Urinary Tract Obstruction Treatment Devices Market growing at a CAGR of 4.2% during the forecast period from 2024 to 2030.

3. What are the drivers for the Global Urinary Tract Obstruction Treatment Devices Market?

The Urinary Tract Obstruction Treatment Devices market is witnessing a positive market growth owing to the growing cases of urological disorders such as bladder cancers, Benign Prostatic Hyperplasia, urolithiasis, or nephrolithiasis, among others. In addition, sedentary lifestyle such as obesity which is a risk factor, innovation in product design, rising old age population across the globe, increase in the number of surgical procedures is thereby contributing to the growth of the Urinary Tract Obstruction Treatment Devices market.

4. Who are the key players operating in the Global Urinary Tract Obstruction Treatment Devices Market?

Some of the key market players operating in the Urinary Tract Obstruction Treatment Devices market include B. Braun Melsungen AG, Boston Scientific Corporation, Cook, Becton, Dickinson, and Company, Teleflex Incorporated, Olympus, Dornier Medtech, EMS Urology, Advin Health Care, Inceler Medikal Co. Ltd., STORZ MEDICAL AG, Shockwave Medical Inc., ACE Medical Devices Pvt. Ltd., Walz Elektronik GmbH, Applied Medical Resources Corporation, Richard Wolf GmbH, Stryker, Urocare Products, Inc., J and M Urinary Catheters LLC, Rocamed, and others.

5. Which region has the highest share in Urinary Tract Obstruction Treatment Devices Market?

North America is expected to hold the highest share in the revenue in the Urinary Tract Obstruction Treatment Devices market during the forecast period. Factors such as the growing cases of urological disorders such as bladder and prostate cancers, urolithiasis, or nephrolithiasis, among others, and increased risk of end-stage renal failure among the population, rising product approvals, are expected to aid in the growth of North America Urinary Tract Obstruction Treatment Devices Market in this region.

Table of Contents

1.Urinary Tract Obstruction Treatment Devices Market Report Introduction

2.Urinary Tract Obstruction Treatment Devices Market Executive Summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment
  • 2.4. Financial Benchmarking

3. Regulatory and Patent Analysis

  • 3.1. The United States
  • 3.2. Europe
  • 3.3. Japan
  • 3.4. China

4. Urinary Tract Obstruction Treatment Devices Market Key Factors Analysis

  • 4.1. Urinary Tract Obstruction Treatment Devices Market Drivers
    • 4.1.1. The Growing Cases of Urological Disorders
    • 4.1.2. Sedentary Lifestyle as a Risk Factor
    • 4.1.3. Innovation in Product Design
    • 4.1.4. Rising Old Age Population Across the Globe
  • 4.2. Urinary Tract Obstruction Treatment Devices Market Restraints and Challenges
    • 4.2.1. The High Cost of Devices
    • 4.2.2. The Adverse Events
  • 4.3. Urinary Tract Obstruction Treatment Devices Market Opportunities
    • 4.3.1. Need For Advanced Devices to Eliminate Inaccurate Diagnosis and Difficulties in Treatment
    • 4.3.2. Growing Preference in Emerging Countries For Minimally Invasive Devices

5. Urinary Tract Obstruction Treatment Devices Market Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Urinary Tract Obstruction Treatment Devices Market

7. Urinary Tract Obstruction Treatment Devices Market Layout

  • 7.1. By Product
    • 7.1.1. Urinary Catheters
      • 7.1.1.1. Indwelling/Foley Catheters
      • 7.1.1.2. Intermittent Catheters
      • 7.1.1.3. External Catheters
    • 7.1.2. Urinary Stents
    • 7.1.3. Shock Wave Lithotripters
      • 7.1.3.1. Intracorporeal
      • 7.1.3.2. Extracorporeal
    • 7.1.4. Ureteroscopes
      • 7.1.4.1. Semi-Rigid
      • 7.1.4.2. Flexible
    • 7.1.5. Resectoscopes
    • 7.1.6. Stone Retrieval Devices
    • 7.1.7. Laser Therapy Systems
    • 7.1.8. Others
  • 7.2. By Indication
    • 7.2.1. Cancers
    • 7.2.2. Stones
    • 7.2.3. Benign Prostatic Hyperplasia (BPH)
    • 7.2.4. Hydronephrosis
    • 7.2.5. Others
  • 7.3. By End-User
    • 7.3.1. Hospitals
    • 7.3.2. Ambulatory Surgical Centers
    • 7.3.3. Others
  • 7.4. By Geography
    • 7.4.1. North America
      • 7.4.1.1. North America Urinary Tract Obstruction Treatment Devices Market, by Product
      • 7.4.1.2. North America Urinary Tract Obstruction Treatment Devices Market, by Indication
      • 7.4.1.3. North America Urinary Tract Obstruction Treatment Devices Market, by End User
      • 7.4.1.4. North America Urinary Tract Obstruction Treatment Devices Market, by Country
      • 7.4.1.4.1. United States
      • 7.4.1.4.2. Canada
      • 7.4.1.4.3. Mexico
    • 7.4.2. Europe
      • 7.4.2.1. Europe Urinary Tract Obstruction Treatment Devices Market, by Product
      • 7.4.2.2. Europe Urinary Tract Obstruction Treatment Devices Market, by Indication
      • 7.4.2.3. Europe Urinary Tract Obstruction Treatment Devices Market, by End User
      • 7.4.2.4. Europe Urinary Tract Obstruction Treatment Devices Market, by Country
      • 7.4.2.4.1. France
      • 7.4.2.4.2. Germany
      • 7.4.2.4.3. United Kingdom
      • 7.4.2.4.4. Italy
      • 7.4.2.4.5. Spain
      • 7.4.2.4.6. Russia
      • 7.4.2.4.7. Rest of Europe
    • 7.4.3. Asia-Pacific
      • 7.4.3.1. Asia-Pacific Urinary Tract Obstruction Treatment Devices Market, by Product
      • 7.4.3.2. Asia-Pacific Urinary Tract Obstruction Treatment Devices Market, by Indication
      • 7.4.3.3. Asia-Pacific Urinary Tract Obstruction Treatment Devices Market, by End User
      • 7.4.3.4. Asia-Pacific Urinary Tract Obstruction Treatment Devices Market, by Country
      • 7.4.3.4.1. China
      • 7.4.3.4.2. Japan
      • 7.4.3.4.3. India
      • 7.4.3.4.4. Australia
      • 7.4.3.4.5. South Korea
      • 7.4.3.4.6. Rest of Asia Pacific
    • 7.4.4. Rest of the World (RoW)
      • 7.4.4.1. RoW Urinary Tract Obstruction Treatment Devices Market, by Product
      • 7.4.4.2. RoW Urinary Tract Obstruction Treatment Devices Market, by Indication
      • 7.4.4.3. RoW Urinary Tract Obstruction Treatment Devices Market, by End User
      • 7.4.4.4. RoW Urinary Tract Obstruction Treatment Devices Market, by Region
      • 7.4.4.4.1. Middle East
      • 7.4.4.4.2. Africa
      • 7.4.4.4.3. South America

8. Urinary Tract Obstruction Treatment Devices Market Global Company Share Analysis - Key 3-5 Companies

9. Urinary Tract Obstruction Treatment Devices Market Company and Product Profiles

  • 9.1. Boston Scientific Corporation
    • 9.1.1. Company Overview
    • 9.1.2. Company Snapshot
    • 9.1.3. Financial Overview
    • 9.1.4. Product Listing
    • 9.1.5. Entropy
  • 9.2. B. Braun Melsungen AG
    • 9.2.1. Company Overview
    • 9.2.2. Company Snapshot
    • 9.2.3. Financial Overview
    • 9.2.4. Product Listing
    • 9.2.5. Entropy
  • 9.3. Advin Health Care
    • 9.3.1. Company Overview
    • 9.3.2. Company Snapshot
    • 9.3.3. Financial Overview
    • 9.3.4. Product Listing
    • 9.3.5. Entropy
  • 9.4. Inceler Medikal Co. Ltd.
    • 9.4.1. Company Overview
    • 9.4.2. Company Snapshot
    • 9.4.3. Financial Overview
    • 9.4.4. Product Listing
    • 9.4.5. Entropy
  • 9.5. Walz Elektronik GmbH
    • 9.5.1. Company Overview
    • 9.5.2. Company Snapshot
    • 9.5.3. Financial Overview
    • 9.5.4. Product Listing
    • 9.5.5. Entropy
  • 9.6. Cook
    • 9.6.1. Company Overview
    • 9.6.2. Company Snapshot
    • 9.6.3. Financial Overview
    • 9.6.4. Product Listing
    • 9.6.5. Entropy
  • 9.7. Becton, Dickinson, and Company
    • 9.7.1. Company Overview
    • 9.7.2. Company Snapshot
    • 9.7.3. Financial Overview
    • 9.7.4. Product Listing
    • 9.7.5. Entropy
  • 9.8. Teleflex Incorporated
    • 9.8.1. Company Overview
    • 9.8.2. Company Snapshot
    • 9.8.3. Financial Overview
    • 9.8.4. Product Listing
    • 9.8.5. Entropy
  • 9.9. STORZ MEDICAL AG
    • 9.9.1. Company Overview
    • 9.9.2. Company Snapshot
    • 9.9.3. Financial Overview
    • 9.9.4. Product Listing
    • 9.9.5. Entropy
  • 9.10. Olympus
    • 9.10.1. Company Overview
    • 9.10.2. Company Snapshot
    • 9.10.3. Financial Overview
    • 9.10.4. Product Listing
    • 9.10.5. Entropy
  • 9.11. EMS Urology
    • 9.11.1. Company Overview
    • 9.11.2. Company Snapshot
    • 9.11.3. Financial Overview
    • 9.11.4. Product Listing
    • 9.11.5. Entropy
  • 9.12. Dornier Medtech
    • 9.12.1. Company Overview
    • 9.12.2. Company Snapshot
    • 9.12.3. Financial Overview
    • 9.12.4. Product Listing
    • 9.12.5. Entropy
  • 9.13. Shockwave Medical Inc.
    • 9.13.1. Company Overview
    • 9.13.2. Company Snapshot
    • 9.13.3. Financial Overview
    • 9.13.4. Product Listing
    • 9.13.5. Entropy
  • 9.14. ACE Medical Devices Pvt. Ltd.
    • 9.14.1. Company Overview
    • 9.14.2. Company Snapshot
    • 9.14.3. Financial Overview
    • 9.14.4. Product Listing
    • 9.14.5. Entropy
  • 9.15. Applied Medical Resources Corporation
    • 9.15.1. Company Overview
    • 9.15.2. Company Snapshot
    • 9.15.3. Financial Overview
    • 9.15.4. Product Listing
    • 9.15.5. Entropy
  • 9.16. Richard Wolf GmbH
    • 9.16.1. Company Overview
    • 9.16.2. Company Snapshot
    • 9.16.3. Financial Overview
    • 9.16.4. Product Listing
    • 9.16.5. Entropy
  • 9.17. Stryker
    • 9.17.1. Company Overview
    • 9.17.2. Company Snapshot
    • 9.17.3. Financial Overview
    • 9.17.4. Product Listing
    • 9.17.5. Entropy
  • 9.18. Urocare Products, Inc.
    • 9.18.1. Company Overview
    • 9.18.2. Company Snapshot
    • 9.18.3. Financial Overview
    • 9.18.4. Product Listing
    • 9.18.5. Entropy
  • 9.19. J and M Urinary Catheters LLC
    • 9.19.1. Company Overview
    • 9.19.2. Company Snapshot
    • 9.19.3. Financial Overview
    • 9.19.4. Product Listing
    • 9.19.5. Entropy
  • 9.20. Rocamed
    • 9.20.1. Company Overview
    • 9.20.2. Company Snapshot
    • 9.20.3. Financial Overview
    • 9.20.4. Product Listing
    • 9.20.5. Entropy

10. KOL Views

11. PROJECT APPROACH

12. About DelveInsight

13. Disclaimer & Contact Us